Search

Ethics Talk: Could Trusting Science Mean Not Trusting Some FDA Decisions?

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Caleb Alexander about the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Click here to read the transcript.

G. Caleb Alexander, MD, MS is professor of epidemiology and medicine at Johns Hopkins Bloomberg School of Public Health.

Video

Recorded on June 22, 2021

Jun 2021

Neurology Patient Care

Audio

Conflict of Interest Disclosure

Dr Alexander is past chair and current member of FDA's Peripheral and Central Nervous System Drugs Advisory Committee. He is a co-founding principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation. He was also a member of OptumRx's National Pharmacy and Therapeutics Committee.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Aug 2013

The Terminally Ill, Access to Investigational Drugs, and FDA Rules

Valarie Blake, JD, MA

Sep 2015

After Equipoise: Continuing Research to Gain FDA Approval

Allison Kerianne Crockett, MD

Jun 2012

Antidepressants and the FDA’s Black-Box Warning: Determining a Rational Public Policy in the Absence of Sufficient Evidence

Dien Ho, PhD

Header Image

Issue Visibility and Measurability in Health Care Off

Bringing Health Professions Education to Patients on the Streets

James S. Withers, MD and Denise Kohl, DO

Health educators have duties to teach patient focus, motivate equity, and cultivate students’ capacity to serve our most vulnerable neighbors, wherever they reside.

AMA J Ethics. 2021;23(11):E858-863. doi: 10.1001/amajethics.2021.858.

Medical Care for the Elderly: Should Limits Be Set? Commentary 1

Daniel Callahan, PhD

Should old folks who have lived their lives be allowed to place a huge economic burden on the young by using a disproportionate amount of limited Medicare resources for medical care?

Virtual Mentor. 2008;10(6):404-407. doi: 10.1001/virtualmentor.2008.10.6.oped1-0806.

Role of Schools in Monitoring Student Health

Benjamin Caballero, MD, PhD

This case poses two important questions. First, do schools have the right or the duty to monitor students’ health status measures and require action from parents and, second, what is the role of a student’s primary care physician in this context?

Virtual Mentor. 2008;9(12):790-793. doi: 10.1001/virtualmentor.2007.9.12.ccas1-0712.

Mandatory Reporting of Noncommunicable Diseases: The Example of The New York City A1c Registry (NYCAR)

Clarissa G. Barnes, Frederick L. Brancati, MD, MHS, and Tiffany L. Gary, PhD, MHS

To combat the rising incidence of type 2 diabetes, New York City requires laboratories with electronic reporting capacity to upload data on hemoglobin A1c measurements to a city department of health registry.

Virtual Mentor. 2007;9(12):827-831. doi: 10.1001/virtualmentor.2007.9.12.pfor2-0712.

AMA Journal of Ethics^®

Illuminating the Art of Medicine

Search Results